ImageneBio, Inc. — Form 8-K

ImageneBio hired Yanina Grant as CFO effective July 20, 2026, at $450K annual base salary plus 40% target bonus (~$180K). She received 95,000 stock options (4-year vest, 1/4 annually then 36 monthly) and 65,000 RSUs (4-year vest, 1/4 annually then 12 quarterly). The company also adopted a Severance and Change in Control Plan (effective April 27, 2026) providing C-Suite executives severance pay, COBRA continuation, and equity acceleration upon covered terminations. Grant's severance terms: 12 months base if terminated without cause outside a change-of-control period; 12 months base plus 100% target bonus plus COBRA/equity acceleration during 12-month change-of-control window.